Blue Horseshoe Stocks: APP, JNUG Reviews & More

American Apparel Inc. APP

When we began pounding the table on APP on Wednesday this week, it was for good reason. On that day we observed a low of .63. The chart was sending out bullish signals left, right, and center, and yesterday proved to be quite a day as the stock made a 58% intraday move from .72-1.14. That high also marked an overall increase of 81% over the low we witnessed the session prior.

APP is maintaining a majority of those gains, trading above a dollar in the premarket today so we’ve been provided with plenty of opportunity to take profits as the stock is on its way up. It remains to be seen if new CEO Paula Schneider can right the ship over time, but for now APP has given us the chance at some excellent short term gains.

Per the chart, 1.20 and 1.30 appear to be the next key areas of resistance. In order for us to remain interested in APP moving forward, we’ll need to see it maintain support at or above the .85-1.00 range.

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve tracked JNUG regularly this fall, and after tagging it in both Tuesday’s and yesterday’s extended watchlist, this ETF has gained a sizable bit of ground. Tuesday’s low was set at 1.82, meaning that as of yesterday’s high at 2.78, we saw a 53% increase out of JNUG over just a three-session span. That low also marked the 52-week low, so our timing here really couldn’t have been any better.

We also want to note that per a recent PR, Direxion will be enacting a 1-for-10 reverse split of the shares of JNUG on Dec. 23rd (This Tuesday).

Other Notable Movers From Yesterday’s Report

Yesterday’s newsletter also yielded an additional three chances to reap intraday profits:

Totally Hemp Crazy Inc. THCZ  -  Range: .013-.018  -  Gain: 38%

Agenus Inc. AGEN
  -  Range: 3.59-3.96  -  Gain: 10%

Real Goods Solar, Inc. RGSE  -  Range: .63-.70  -  Gain: 11%

Extended Watchlist:

Blue Horseshoe Stocks: APP, CERS Recaps & More

American Apparel Inc. APP

It appears as if we brought APP back into the discussion yesterday at an opportune time, as the stock enjoyed a healthy intraday move on more than twice the 3-month average trading volume.

After briefly seeing a low of .63 the stock gradually built its way up to an afternoon high of .69, an increase of roughly 10%, and in the premarket this morning APP has already traded as high as .78. That pushes the overnight increase on APP to 24%

Yesterday we mentioned that breaking of the 200DMA of .74 was a key event that needed to take place and we’ve seen that happen this morning, so APP is certainly going to remain high on our watchlists as we head into week’s end.

Cerus Corp. CERS

CERS was included in yesterday’s extended watchlist, and made a solid move during the day’s session. From a low of 5.26 the stock made a run at a high of 5.94, a modest yet notable 13% increase.

It came on the heels of the announcement that the company had received the green light from the FDA on its product that limits the risk of infection-transmission in blood transfusions. We always like a good FDA-approval play so we will definitely be monitoring this play in coming sessions.

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection (TTI) when treating patients requiring therapeutic plasma transfusion. >> FULL PR

Eco Science Solutions, Inc. ESSI

We’ve still got ESSI on our radars, and wanted to remind our readers of this even as the stock has been trading in a tight channel between .20-.25 since we last took a look at it. The reason we still find ESSI attractive is that it boasts a tight share structure, and while we haven’t seen much in the way of volume, should that change, even the slightest amount of buying pressure could send ESSI flying.

From a business perspective, we’re also interested in the technology the company is working on, its innovative re-imagining on classic spark plug design. So despite not seeing much short-term activity, ESSI still has many of the hallmarks of a high-potential play that we’ll want to watch closely into the New Year.

We’ve drawn up a video on the current standing of the ESSI Chart, so take a look at that by clicking the graphic below:

If you missed our initial report on ESSI and its spark plug technology, go ahead and take a look now: ESSI Report

Extended Watchlist:

Blue Horseshoe Stocks: Revisiting APP & More

American Apparel Inc. APP

This fall, for the first time in a long time, APP failed to see the increases that have coincided with the beginning of the retail season in recent years. Instead, here we are nearing the end of the heaviest shopping days of the year, and the stock is just now beginning to show signs of life.

CEO Dov Charney, thought by many to be one of the worst CEO’s on Wall Street, has been fired by the board of directors per a PR released this morning. His official dismissal amid allegations of misconduct is sitting well with investors, with the stock trading up significantly in premarket activity. We’ll be interested to follow APP more closely as the reigns are handed over to Paula Schneider on January 5th, and if she can turn APP back in a positive direction as the new CEO. >> Read About Charney’s Firing

Looking at the chart, the last time APP was trading as low as it has been in recent weeks was early this summer, just before the stock ran to over 1.20. We’ve covered APP for many years and have witnessed numerous big runs, so it wouldn’t be surprising to see a extended recovery off of these 6-month lows, if the stock can get over the hurdle that is the current 200DMA (.74). Beyond that, APP will have to contend with resistance points at .77, .85, and 1.09.

InterCloud Systems, Inc. ICLD

During this time of the year when tax-loss selling drives many stocks down to annual lows, we’re always on the lookout for a good bottom-bounce play. ICLD may fit that description. The stock touched 52-week low of 2.77 yesterday, and is currently trending up in the premarket.

The company released a PR this morning announcing  that its new business backlog was at record highs, ($32M) according to CEO Mark Munro, “This is a tribute to our growing sales organization and a competitive edge in our markets. InterCloud’s sales pipeline continues to grow month over month offering great upside as we move into 2015.” >>READ PR 

Extended Watchlist:

Blue Horseshoe Stocks: TLM, HGSH & FRO Recaps

Talisman Energy, Inc. TLM

We began tracking TLM on Friday after noticing the stock coming up off of its recently-registered 52-week low, and on that day we observed a low of 4.17.

The stock made higher highs and higher lows yesterday following another inclusion in our morning report, making definite progress, but with a surprise buyout announcement early this morning the PPS has gone into overdrive.  The all-cash transaction is valued at $8 Billion, and has been unanimously approved on all sides.

CALGARY, ALBERTA–(Marketwired – Dec 16, 2014) – Talisman Energy Inc. (TLM.TO)(TLM) is pleased to announce that it has entered into a definitive agreement (the “Arrangement Agreement”) with Repsol S.A. under which Repsol will acquire all of the outstanding common shares of Talisman for US$8.00 (C$9.33) per share in cash. >> FULL PR

The premarket high thus far today stands at 7.74, which marks an increase of 85% that we’ve witnessed in TLM over the course of just a few days. Congrats to anyone who caught our pre-emptive alert and was able to take advantage!

China HGS Real Estate, Inc. HGSH

Another winning call off of yesterday’s report was HGSH; the stock appeared in our extended watchlist, and went on to have quite a fruitful session. The stock would open and briefly touch a low of 4.63 before spending the rest of the day on the rise, culminating in an afternoon high of 5.96.

That solid intraday move came on more than 10 the 3-month average volume, and represented a highly respectable increase of 29%

Frontline Ltd. FRO

Despite seeing a gap-down in this morning’s pre-market on the heels of a debt-for-equity program announced by FRO, we did see a nice move out of the stock yesterday after including it in our last couple of newsletters. It made an intraday move from 2.53 to 2.95 (+17%).

We observed a low of 1.88 on Friday, meaning that yesterday’s high figured in as a two-day overall increase of 57%

BioLineRx Ltd. BLRX

BLRX also appeared in yesterday’s extended watchlist, and while it had a tough time getting going yesterday, the stock is up significantly in today’s premarket activity on the strength of a new PR so we’ll be sure to monitor the situation as the week progresses.

The company has signed an agreement with pharma-giant Novartis, under which Novartis has made an initial equity investment in BLRX of $10M for 12.8% of BLRX’s current shares outstanding. Read more about it in the following news announcement:

Blue Horseshoe Stocks: FRO, OPK, WLGC & More

Frontline, Ltd. FRO

At the beginning of this month when we first began looking at FRO, the stock was trading at a low of 1.33. It took barely a week for the stock to start inching its way up, and it has continued to do so up to the present.

By the time we re-flagged it in Friday’s morning report, it had already cracked the $2.00-mark, and we did mention that the level of momentum was primed to allow for further opportunities.

This morning FRO continues to push the envelope, setting a new high in premarket trading action. This morning’s top figure of 2.64 puts us just slightly short of double-bagger status, having shown us an increase of 98% from the lows we observed the week before last.

It can be argued that the bolstering of activity seen on FRO (and other shipping plays) is due to the continuing fall of oil prices which translates to savings at the pump.

Opko Health, Inc. OPK

OPK is catching our attention in the premarket as well, as a result of an agreement announced this morning with pharma-giant Pfizer to develop and commercialize one of Opko’s highly promising products which combats Growth Hormone deficiency. Peruse the following PR to find out more; the development certainly lands OPK a spot on our watchlist to kick off the week.

In instances like these where a play is sent through the roof on substantial news, we look for the resulting profit-taking to pull the stock back, where we wait to take advantage of a possible dip-and-rip scenario.

OPKO Health, Inc. (OPK) and Pfizer Inc. (PFE) announced today that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD)… hGH-CTP has the potential to reduce the required dosing frequency of human growth hormone to a single weekly injection from the current standard of one injection per day. >> FULL PR

WordLogic Corp. WLGC

Speaking of significant news, WLGC forces its way into our vernacular this morning on the heels of the announcement that the company will be teaming up with energy-leviathan General Electric (GE) in order to “monetize specific patented intellectual property in General Electric’s portfolio.”

With such a high-profile bedfellow, WLGC will instantly gain new recognition, and it will be very interesting to see how that translates to the chart.

Notable Gainers from Friday’s Extended Watchlist

Oncothyreon, Inc. ONTYRange: 1.69-2.05   Gain: 21%

Organovo Holdings, Inc. ONVORange: 5.82-6.50  Gain: 11%

Extended Watchlist: